Neoantigen cancer vaccines: a new star on the horizon
Immunotherapy represents a promising strategy for cancer treatment that utilizes immune cells or drugs to activate the patient’s own immune system and eliminate cancer cells. One of the most exciting advances within this field is the targeting of neoantigens, which are peptides derived from non-syno...
Main Authors: | Xiaoling Li, Jian You, Liping Hong, Weijiang Liu, Peng Guo, Xishan Hao |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2024-04-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | https://www.cancerbiomed.org/content/21/4/274 |
Similar Items
-
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
by: Jiangping Li, et al.
Published: (2023-08-01) -
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
by: Zhi Pang, et al.
Published: (2023-12-01) -
Structural basis for T cell recognition of cancer neoantigens and implications for predicting neoepitope immunogenicity
by: Roy A. Mariuzza, et al.
Published: (2023-11-01) -
T Cell Based Immunotherapy for Cancer: Approaches and Strategies
by: Muzamil Y. Want, et al.
Published: (2023-04-01) -
The landscape of neoantigens and its clinical applications: From immunobiology to cancer vaccines
by: Chiranjib Chakraborty, et al.
Published: (2024-01-01)